Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-04

Clinical Trial Update: Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]

View source ↗

Summary

This is a completed all-case surveillance trial assessing Enbrel (etanercept) use in Juvenile Idiopathic Arthritis, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Juvenile Idiopathic Arthritis | Status: COMPLETED | Results posted: 2014-09-04